X. Wu

Discovery of small-molecule inhibitors of Bcl-2 through structure-based computer screening.

I. Enyedy, Y. Tomita, P. Roller, 2001, Journal of medicinal chemistry.

Rational design, synthesis, and biological evaluation of rigid pyrrolidone analogues as potential inhibitors of prostate cancer cell growth.

B. Roth, J. Flippen-Anderson, Shaomeng Wang, 2001, Bioorganic & medicinal chemistry letters.

Functional preference of the constituent amino acid residues in a phage-library-based nonphosphorylated inhibitor of the Grb2-SH2 domain.

P. Roller, F. Lung, X. Wu, 2001, The journal of peptide research : official journal of the American Peptide Society.

Tumor specific novel taxoid-monoclonal antibody conjugates.

X. Wu, I. Ojima, 2002, Current medicinal chemistry.

Chalcones: an update on cytotoxic and chemoprotective properties.

X. Wu, X. L. Liu, M. Go, 2005, Current medicinal chemistry.

Structure-based design and synthesis of small molecule protein-tyrosine phosphatase 1B inhibitors.

L. Wu, T. Burke, Z. Zhang, 1998, Bioorganic & medicinal chemistry.

Synthesis and biological activity of a bivalent nucleotide inhibitor of ribonucleotide reductase.

B. Cooperman, X. Wu, 2000, Bioorganic & medicinal chemistry letters.

Toward a rational design of peptide inhibitors of ribonucleotide reductase: structure-function and modeling studies.

B. Cooperman, P. Axelsen, X. Wu, 2001, Journal of medicinal chemistry.

Conformational analysis of the major DNA adduct derived from the food mutagen 2-amino-3-methylimidazo[4,5-f]quinoline.

S. Broyde, R. Shapiro, X. Wu, 1999, Chemical research in toxicology.

Discovery of small-molecule inhibitors of Bcl-2 through structure-based computer screening.

I. Enyedy, Y. Tomita, P. Roller, 2001, Journal of medicinal chemistry.